title: Origins of heterogeneous ovarian carcinomas. A molecular cytogenetic analysis of histologically benign, low malignant potential, and fully malignant components.
abstract: It is unclear whether ovarian carcinomas develop from malignant transformation of benign precursors or whether they arise de novo. Thus, histologically benign or low malignant potential components found in heterogeneous ovarian carcinomas may be remnants of pre-existing lesions that progressed to malignancy or, alternatively, elements that arose independently (de novo). In a third possible interpretation, they represent areas of malignant epithelium that matured. We evaluated clonal relationships of histological components in 10 heterogeneous ovarian carcinomas using fluorescence in situ hybridization and confocal microscopy. Detailed analysis of aneuploidy for chromosomes 8, 12, and 17 on intact paraffin sections revealed that two tumors were aneuploid in all components, two lacked abnormalities in benign-appearing components, and one lacked aneuploidy in both histologically benign and low malignant potential components. Histological appearance was significantly related to aneuploidy (P < 0.05). The distribution of aneuploidy among tumor components strongly supports the tumor progression theory and demonstrates that the de novo hypothesis is highly unlikely (P < 0.001). Results also indicate that benign-appearing components in heterogeneous ovarian carcinomas do not represent maturation of malignant tissue and suggest that some benign tumors that become cancerous may have genetic aberrations that predispose them to malignant transformation.
authors.affiliation: Department of Genetics, Case Western Reserve University, Cleveland, Ohio 44106, USA.
authors.forename: N G
authors.initials: NG
authors.lastname: Wolf
authors.forename: F W
authors.initials: FW
authors.lastname: Abdul-Karim
authors.forename: N J
authors.initials: NJ
authors.lastname: Schork
authors.forename: S
authors.initials: S
authors.lastname: Schwartz
mesh_terms: D000782:Aneuploidy; D016009:Chi-Square Distribution; D003582:Cytogenetics / Q000379:methods*; D018450:Disease Progression; D005260:Female; D005838:Genotype; D006801:Humans; D017404:In Situ Hybridization, Fluorescence / Q000379:methods; D018613:Microscopy, Confocal; D010051:Ovarian Neoplasms / Q000235:genetics / Q000473:pathology*